ArticleClinical ophthalmology (Auckland, N.Z.)2026
Comparison of Visual Performance and Patient Satisfaction Between Two Trifocal Intraocular Lenses: A Prospective, Paired-Eye Comparative Study.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A Comparative Study of the Visual Outcomes of Two Common Diffractive Trifocal Intraocular Lenses in a Matched Cohort.Cureus · 2026Article
- Optimizing Cataract Surgery Workflows Across a Multi-Satellite Tertiary Care Center.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
- Clinical Outcomes Following Bilateral Implantation of TECNIS Odyssey Intraocular Lenses in Japanese Eyes.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Clinical Outcomes Following Bilateral Implantation of a Next-Generation Intraocular Lens in Patients with Primary Open Angle Glaucoma.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Clinical outcomes of effectiveness and safety in cataract patients implanted with the novel hybrid extended depth-of-focus intraocular lens AM2UH: a prospective study.Frontiers in medicine · 2026Article
- Short-Term Visual and Optical Performance of the ZEISS CT LUCIA 621P Intraocular Lens Across Different Power Ranges.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study compared the visual performance, patient-reported outcomes, and spectacle independence of two advanced trifocal intraocular lens (IOL) platforms, Clareon PanOptix and TECNIS Odyssey, in a paired-eye design. The primary hypothesis was that differences in optical design would yield distinct strengths in distance, intermediate, and near visual acuity (VA), contrast sensitivity (CS), and patient satisfaction. Patients and Methods: In this prospective, single-center, single-surgeon trial at the Bascom Palmer Eye Institute, 19 patients (38 eyes; mean age 66.37 ± 10.61 years) undergoing bilateral cataract surgery were stratified by ocular dominance and randomized for dominant-eye IOL allocation. Each patient received a PanOptix (toric or non-toric) in one eye and an Odyssey (toric or non-toric) in the fellow eye, implanted one week apart. Postoperative assessments (≥1 month) included monocular distance-corrected VA at distance (CDVA, 4 m), intermediate (DCIVA, 60 cm), and near (DCNVA, 40 cm), uncorrected VAs, residual refraction, CS, and patient-reported visual quality and spectacle independence. Results: Compared with PanOptix, Odyssey achieved significantly better CDVA (EMD=0.03 logMAR, 95% CI [0.01, 0.06], Conclusion: In a paired-eye comparison, PanOptix provided superior intermediate VA, while Odyssey delivered better distance VA and CS. Both lenses yielded high spectacle independence and comparable rates of photic phenomena, supporting their viability as presbyopia-correcting options in cataract surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.